1-5 of 5
Arnon Nagler, MD MHA
Close
Sort by
Journal Articles

Haploidentical Versus Autologous Stem Cell Transplantation in Adult Acute Leukemia: A Matched Pair Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Norbert Claude Gorin, MD PhD, Myriam Labopin, MD, Simona Piemontese, MD, Fabio Ciceri, MD, Arnon Nagler, MD MHA, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2508.
https://doi.org/10.1182/blood.V124.21.2508.2508
Published: 2014
Journal Articles

Cathecholamines Differently Regulate Human AML and Normal Hematopoietic Progenitor Cell Motility Via miR126 and RGS16

Abraham Avigdor, MD, Chiara Medaglia, PhD, Alexander Kalinkovich, MD, PhD, Tomer Itkin, PhD, Menachem Bitan, MD, PhD, Arnon Nagler, MD, MHA, Tsvee Lapidot, PhD
Journal: Blood
Blood (2013) 122 (21): 1413.
https://doi.org/10.1182/blood.V122.21.1413.1413
Published: 2013
Journal Articles

Jewish Immigrants Of Middle Eastern Origin Have a Lower Incidence Of Multiple Myeloma Compared To Both North African and European Jews In a Cohort Of 746,200 Israeli Men Followed From Late Adolescence

Merav Leiba, MD, Arnon Afek, MD, Estela Derazne, MA, Adi Leiba, MD, MHA, Lital Keinan-Boker, MD, Ari Shamiss, MD, MHA, Arnon Nagler, MD, MHA, Jeremy D. Kark, MD
Journal: Blood
Blood (2013) 122 (21): 5346.
https://doi.org/10.1182/blood.V122.21.5346.5346
Published: 2013
Journal Articles

Donor Lymphocyte Infusion Vs. Second Allogeneic HCT In Relapsed AML After Allografting: A Landmark Analysis From The Acute Leukemia Working Party Of EBMT

Mohamed A Kharfan-Dabaja, Myriam Labopin, Taiga Nishihori, Ali Bazarbachi, Jürgen Finke, Gerhard Ehninger, Matthias Stelljes, Nicolaus Kroeger, Bruno Lioure, MD, Arnon Nagler, MD, MHA, Lothar Kanz, Johanna Tischer, Ernst Holler, Christoph Schmid, Mohamad Mohty
Journal: Blood
Blood (2013) 122 (21): 3330.
https://doi.org/10.1182/blood.V122.21.3330.3330
Published: 2013
Journal Articles

Conditioning Intensity In Middle Aged Patients With AML In CR1. No Advantage For Myeloablative Regimens Irrespective Of The Risk Group. An Observational Analysis By The Acute Leukemia Working Party Of The EBMT

Jakob Passweg, Myriam Labopin, MD, Jan J Cornelissen, MD, PhD, Liisa Volin, MD, Gérard Socié, MD, PhD, Anne Huynh, Reza Tabrizi, MD, Depei Wu, MD, Charles Craddock, MD, Nicolaas PM Schaap, MD, PhD, Jurgen H Kuball, MD, PhD, Patrice Chevallier, MD, PhD, Jean-Yves Cahn, MD, PhD, Didier Blaise, MD, Ardeshir Ghavamzadeh, MD, Karin Bilger, MD, Arnon Nagler, MD, MHA, Fabio Ciceri, MD, Christoph Schmid, Sebastian Giebel, MD, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 542.
https://doi.org/10.1182/blood.V122.21.542.542
Published: 2013